- Home
- OLMA vs RVNC Comparison
OLMA vs RVNC Comparison
Compare OLMA & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- RVNC
- Stock Information
- Founded
- OLMA 2006
- RVNC 1999
- Country
- OLMA United States
- RVNC United States
- Employees
- OLMA N/A
- RVNC N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- OLMA Health Care
- RVNC Health Care
- Exchange
- OLMA Nasdaq
- RVNC Nasdaq
- Market Cap
- OLMA 465.4M
- RVNC 320.5M
- IPO Year
- OLMA 2020
- RVNC 2014
- Fundamental
- Price
- OLMA $6.10
- RVNC $3.09
- Analyst Decision
- OLMA Strong Buy
- RVNC Hold
- Analyst Count
- OLMA 5
- RVNC 9
- Target Price
- OLMA $26.25
- RVNC $8.45
- AVG Volume (30 Days)
- OLMA 1.2M
- RVNC 3.6M
- Earning Date
- OLMA 11-12-2024
- RVNC 11-07-2024
- Dividend Yield
- OLMA N/A
- RVNC N/A
- EPS Growth
- OLMA N/A
- RVNC N/A
- EPS
- OLMA N/A
- RVNC N/A
- Revenue
- OLMA N/A
- RVNC $256,945,000.00
- Revenue This Year
- OLMA N/A
- RVNC $11.28
- Revenue Next Year
- OLMA N/A
- RVNC $27.21
- P/E Ratio
- OLMA N/A
- RVNC N/A
- Revenue Growth
- OLMA N/A
- RVNC 25.82
- 52 Week Low
- OLMA $5.56
- RVNC $2.30
- 52 Week High
- OLMA $16.78
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- OLMA 27.05
- RVNC 33.47
- Support Level
- OLMA $5.56
- RVNC $3.06
- Resistance Level
- OLMA $6.87
- RVNC $3.09
- Average True Range (ATR)
- OLMA 0.81
- RVNC 0.11
- MACD
- OLMA -0.28
- RVNC 0.02
- Stochastic Oscillator
- OLMA 10.12
- RVNC 6.90
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.